Steve E. Krognes
2020
In 2020, Steve E. Krognes earned a total compensation of $4.3M as Chief Financial Officer and Treasurer at Denali Therapeutics, a 69% increase compared to previous year.
Compensation breakdown
| Bonus | $387,362 |
|---|---|
| Option Awards | $2,018,444 |
| Salary | $484,200 |
| Stock Awards | $1,364,638 |
| Other | $11,400 |
| Total | $4,266,044 |
Krognes received $2M in option awards, accounting for 47% of the total pay in 2020.
Krognes also received $387.4K in bonus, $484.2K in salary, $1.4M in stock awards and $11.4K in other compensation.
Rankings
In 2020, Steve E. Krognes' compensation ranked 2,668th out of 13,090 executives tracked by ExecPay. In other words, Krognes earned more than 79.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,668 out of 13,090 | 80th |
Division Manufacturing | 1,024 out of 5,620 | 82nd |
Major group Chemicals And Allied Products | 377 out of 2,253 | 83rd |
Industry group Drugs | 325 out of 1,953 | 83rd |
Industry Biological Products, Except Diagnostic Substances | 87 out of 411 | 79th |
Source: SEC filing on April 22, 2021.
Krognes' colleagues
We found three more compensation records of executives who worked with Steve E. Krognes at Denali Therapeutics in 2020.
News
Denali Therapeutics CEO Ryan Watts' 2021 pay jumps 36% to $13M
April 19, 2022
Denali Therapeutics CEO Ryan Watts' 2020 pay jumps 87% to $9.3M
April 22, 2021
Denali Therapeutics CEO Ryan Watts' 2019 pay slips 17% to $5M
April 22, 2020
Denali Therapeutics CEO Ryan Watts' 2018 pay jumps 338% to $6M
April 18, 2019